0001209191-19-045633.txt : 20190812
0001209191-19-045633.hdr.sgml : 20190812
20190812190847
ACCESSION NUMBER: 0001209191-19-045633
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190808
FILED AS OF DATE: 20190812
DATE AS OF CHANGE: 20190812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Popovits Kimberly J
CENTRAL INDEX KEY: 0001333482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 191017952
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-08
0
0001131324
GENOMIC HEALTH INC
GHDX
0001333482
Popovits Kimberly J
301 PENOBSCOT DR.
REDWOOD CITY
CA
94063
1
1
0
0
President and CEO
Common Stock
2019-05-29
5
G
0
E
800
0.00
D
108152
I
Held by the Popovits 2010 Trust
Common Stock
2019-08-08
4
M
0
25000
29.34
A
133468
I
Held by the Popovits 2010 Trust
Common Stock
2019-08-08
4
S
0
15765
73.6312
D
117703
I
Held by the Popovits 2010 Trust
Common Stock
2019-08-08
4
S
0
9235
74.2252
D
108468
I
Held by the Popovits 2010 Trust
Common Stock
2019-08-09
4
M
0
25000
29.34
A
133468
I
Held by the Popovits 2010 Trust
Common Stock
2019-08-09
4
S
0
24000
73.6322
D
109468
I
Held by the Popovits 2010 Trust
Common Stock
2019-08-09
4
S
0
1000
74.3691
D
108468
I
Held by the Popovits 2010 Trust
Common Stock
12298
I
Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits
Common Stock
36168
D
Employee Stock Option (right to buy)
29.34
2019-08-08
4
M
0
25000
0.00
D
2022-02-05
Common Stock
25000
65000
D
Employee Stock Option (right to buy)
29.34
2019-08-09
4
M
0
25000
0.00
D
2022-02-05
Common Stock
25000
40000
D
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $73.03 to $74.02.
Represents weighted average sale price. Actual sale prices ranged from $74.03 to $74.39.
Represents weighted average sale price. Actual sale prices ranged from $73.24 to $74.15.
Represents weighted average sale price. Actual sale prices ranged from $74.24 to $74.45.
Represents shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2019-08-12